|
Probability to be free from functional disability in the year before death of cancer patients by selected characteristics |
||||||||
| Probability to be free from functional disability (weeks before death) |
||||||||
|
|
||||||||
| N. |
52 weeks % (95% CI) |
24 weeks % (95% CI) |
18 weeks % (95% CI) |
12 weeks % (95% CI) |
6 weeks % (95% CI) |
4 weeks % (95% CI) |
2 weeks % (95% CI) |
|
| Gender |
||||||||
| Men |
700 |
95 (93–97) |
92 (89–94) |
91 (88–93) |
68 (63–73) |
53 (49–58) |
39 (35–44) |
27 (23–31) |
| Women |
549 |
92 (89–94) |
88 (84–91) |
86 (82–89) |
56 (51–62) |
43 (37–48) |
26 (21–31) |
18 (15–22) |
| Age at death |
||||||||
| 18–64 |
242 |
99 (96–99) |
95 (91–97) |
93 (89–96) |
74 (68–80) |
62 (55–68) |
43 (36–50) |
30 (25–36) |
| 65–84 |
785 |
94 (92–96) |
92 (89–94) |
90 (86–92) |
63 (58–68) |
47 (43–51) |
32 (28–36) |
22 (19–25) |
| 85 + |
222 |
85 (79–90) |
80 (74–85) |
79 (73–84) |
50 (42–58) |
41 (34–47) |
28 (23–33) |
19 (14–24) |
| Primary Tumour |
||||||||
| Digestive |
453 |
94 (92–96) |
91 (88–94) |
90 (87–92) |
65 (60–70) |
53 (48–58) |
35 (30–40) |
23 (19–27) |
| Respiratory |
262 |
97 (93–99) |
94 (90–96) |
91 (85–95) |
69 (61–76) |
52 (45–59) |
39 (32–46) |
28 (23–34) |
| Breast |
124 |
91 (83–95) |
88 (80–93) |
87 (80–91) |
58 (49–67) |
45 (35–55) |
24 (15–37) |
19 (12–29) |
| Genitourinary |
184 |
93 (87–97) |
87 (80–92) |
85 (80–90) |
59 (49–68) |
41 (33–49) |
28 (21–36) |
15 (11–23) |
| Hematological |
91 |
91 (83–95) |
90 (82–94) |
88 (80–93) |
62 (52–72) |
52 (42–62) |
40 (32–49) |
30 (22–40) |
| Nervous Central System |
32 |
87 (67–96) |
76 (59–87) |
72 (56–84) |
46 (26–68) |
35 (19–55) |
14 (5–31) |
6 (2–19) |
| Others |
103 |
92 (84–96) |
90 (82–95) |
90 (81–95) |
60 (44–74) |
42 (31–55) |
37 (27–49) |
28 (18–40) |
| All patients |
1,249 |
94 (92–95) |
90 (88–93) |
88 (86–91) |
63 (58–68) |
49 (45–53) |
33 (30–37) |
23 (20–26) |
Costantini et al. BMC Cancer 2008 8:127 doi:10.1186/1471-2407-8-127 |
||||||||